Nanotechnology Now - Press Release: Implant Sciences Ships Six Benchtop Explosives Detector Systems for Use in Beijing 2008 Olympic Games

Home > Press > Implant Sciences Ships Six Benchtop Explosives Detector Systems for Use in Beijing 2008 Olympic Games

Abstract:
Quantum Sniffer BTS Benchtop Explosives Detection System to Be Used by Beijing Police as Part of 2008 Olympics Security and Anti-Terrorism Efforts

Implant Sciences Ships Six Benchtop Explosives Detector Systems for Use in Beijing 2008 Olympic Games

WAKEFIELD, MA | Posted on October 9th, 2007

Implant Sciences Corporation (AMEX: IMX) today announced the shipment of six (6) units of the Company's Quantum Sniffer BTS Benchtop Explosives Detection System ("QS-BTS") to Beijing Ritchie's Time Co., Ltd, the Company's distributor in China, for delivery to the Beijing police. The QS-BTS, along with previously shipped Quantum Sniffer H100 ("QS-H100") and H150 ("QS-H150") Portable Explosives Detectors, is expected to be used in connection with security and anti-terrorism efforts during the 2008 Olympic Games to be held in Beijing.

In a recent online publication of Homeland Security Daily Wire, one high ranking official of the Ministry of Public Security in China indicated that terrorism posed the biggest threat to the holding of a successful Beijing Olympic Games. A second high ranking official of the Ministry also noted that although the Olympic Games are a happy gathering for people from all countries, it is also a big target for terrorism.

The QS-BTS, using the Company's patented Vortex collector technology for sample collection and Quantum Sniffer technology for explosives detection, provides the advanced analytical capabilities expected of a desktop detection device while providing the flexibility of a portable, handheld detection device - all in one easy to use unit. The Vortex collector technology, which offers the ability to collect samples of vapors and particulate matter in both non-contact and contact modes, is combined with the Quantum Sniffer detection technology making possible the detection of nanogram (i.e., parts per trillion) amounts of a variety of explosive substances commonly used by terrorists.

Phillip C. Thomas, Implant Sciences President and CEO, commented, "We are pleased to play a role in providing advanced technology tools to help improve security and combat terrorist threats that may be faced in connection with the Beijing 2008 Olympic Games. The Company has established a presence within China over the past two years and has developed a significant installed base of its QS-H100 and QS-H150 Portable Explosives Detection Systems. This new shipment of our QS-BTS Benchtop Explosives Detector Systems represents our first installation of the Benchtop version of our technology in China. The QS-BTS represents state-of-the-art technology for the detection of vapors and minute particles of explosives materials in a security checkpoint environment. We look forward to increased success in the worldwide marketing and sales of this new product which is complimentary to our QS-H150 Portable Explosives Detector."

####

About Implant Sciences Corporation
Implant Sciences develops, manufactures and sells products through its primary business units: (i) explosives trace detection (ETD) systems for homeland security, defense, and other security related applications and (ii) state of the art services for the medical and semiconductor industries. The Company has developed proprietary technology used in its commercial portable and bench-top ETD systems, which ship to a growing number of locations around the world and domestically, and is developing additional next-generation ETD systems.

The Company’s ETD products address many important security needs in aviation, cargo, transportation, and other related elements of the government and commercial infrastructure. In addition to its security market focus, the Company provides high technology coatings for a variety of medical products at its main facility in Wakefield, Massachusetts and provides ion implantation services to the semiconductor industry in a state-of-the-art facility in Sunnyvale, California. For further details on the Company and its products, please visit the Company’s new website at www.implantsciences.com.

Implant Sciences believes this press release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks and uncertainties. Such statements are based on management's current expectations and are subject to facts that could cause results to differ materially from the forward-looking statements.

For further information you are encouraged to review Implant Sciences’ filings with the Securities and Exchange Commission, including its Annual Report on Form 10K for the period ended June 30, 2006 and Quarterly Reports on Form 10Q for the periods ended September 30, 2006, December 31, 2006 and March 31, 2007. The Company assumes no obligation to update the information contained in this press release.

For more information, please click here

Contacts:

Implant Sciences Corporation
Investor Relations, 781-246-0700 ext. 105 or 508-523-3141

or
Catalyst Financial Resources
Thomas T. O’Brien, 503-757-4903

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark: